FindTrial
Sign In

Determination of serum and cerebrospinal fluid anti-NMDAR antibodies in children with Japanese encephalitis and its clinical significance

Determination of serum and cerebrospinal fluid anti-NMDAR antibodies in children with Japanese encephalitis and its clinical significance

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-COC-17012455
Enrollment
Unknown
Registered
2017-08-23
Start date
2017-08-24
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese encephalitis

Interventions

1:No

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1) During the summer outbreaks of JE; 2) Having clinical presentation of encephalitis:high fever,headache,vomiting,convulsion,altered consciousness; 3) Laboratory confirmed: JE virus-specific immunoglobulin M (IgM) antibody in serum or cerebrospinal fluid is positive by IgM-capture ELISA; 4) The course of illness is within 1 week.

Exclusion criteria

Exclusion criteria: Due to the severity of the disease, acute stage is not suitable for lumbar puncture

Design outcomes

Primary

MeasureTime frame
anti-NMDAR antibodies;—

Countries

China

Contacts

Public ContactMa Jiannan

Children's Hospital of Chongqing Medical University,

mjn023@126.com13274006848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026